Archive for January 2019

ImmunoPrecise Appoints Lisa Helbling as Chief Financial Officer

VICTORIA, January 14, 2019 / – IMMUNOPRECISE ANTIBODIES LTD. (the “Company” or “IPA”) (TSX VENTURE: IPA) (OTC PINK: IPATF) is pleased to announce that it has appointed Lisa Helbling as Chief Financial Officer. Lisa Helbling brings over 30 years of experience in accounting, financing, and business development within the public markets and has a demonstrated ability … Continue reading

ImmunoPrecise Antibodies Will Be in San Francisco During J.P. Morgan Healthcare Conference Week January 7-10, 2019

VICTORIA, January 3, 2019 / – IMMUNOPRECISE ANTIBODIES LTD. (the “Company” or “IPA”) (TSX VENTURE: IPA) (OTC PINK: IPATF) announced today IPA will be in San Francisco during the J.P. Morgan 37th Annual Healthcare Conference events running from January 7-10, 2019 in San Francisco, California. Thirty-seven years ago, J.P. Morgan launched Wall Street’s premier investor … Continue reading

ImmunoPrecise Hires Jason Orloske as Vice President Operations

VICTORIA, Dec. 26, 2018 /CNW/ – IMMUNOPRECISE ANTIBODIES LTD. (the “Company” or “IPA”) (TSX VENTURE: IPA) (OTC PINK: IPATF) is pleased to announce Jason Orloske has accepted the position of Vice President of Operations for ImmunoPrecise Antibodies Global Division reporting directly to Dr. Jennifer Bath, CEO and President. As Vice President of Operations, Jason Orloske, PMP, CSP, is responsible for operationalizing strategic initiatives … Continue reading